Addiction: A path to medicines for treatment - Sanford Burnham Prebys
Event

Addiction: A path to medicines for treatment

An Insights Series event with Nicholas Cosford, PhD, Michael Jackson, PhD and Douglas Sheffler, PhD

DateOct 27, 2020
Time2:00-3:00PM PT
Location
Zoom
Get Directions

From painkillers to stimulants to nicotine—addiction is real…and rampant. In the U.S., more than 20 million people have at least one addiction, yet effective treatments are woefully lacking.Economically, it’s estimated that substance abuse leads to $740 billion per year in costs related to crime, lost work, productivity and healthcare.

Sanford Burnham Prebys scientists believe they are on a path to help people fight addiction.

Hear from our top researchers on the prospects of a novel therapy to treat people who suffer from substance abuse, and how this may help them from relapsing after successful treatment. Join us as we share our breakthroughs and discoveries, including details of a clinical trial to move this critical research forward. 

A Q&A session will follow the presentation and will give you an opportunity to personally connect with our scientists and have your questions answered.

Don’t miss this chance to connect with our scientists and have your questions answered!
 

Event recording


nicholas-cosford_vt9p0932_c_1-3


Nicholas Cosford, PhD

Deputy Director

NCI-Designated Cancer Center

Professor

Cancer, Molecules and Structures Program


michael-jackson-phd_c_1-3


Michael Jackson, PhD

Senior Vice President, Drug Discovery and Development

Conrad Prebys Center for Chemical Genomics

Professor

Cancer, Molecules and Structures Program

NCI-Designated Cancer Center


douglas-sheffler-phd_4230_c_1-3


Douglas Sheffler, PhD

Research Assistant Professor

Cancer, Molecules and Structures Program

NCI-Designated Cancer Center